InsiderTradesSIGMA

PicksTOP Companies Executives Performance Blog Topics

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FRUSDEGBCHCAITESNLBENOSEFIDKAUATIEBRINJP+ 8 markets

Recommendations
Companies
Insiders
Performance
Backtest
Compare

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 28 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

Theme: dark (range regime detected on CAC40 90d · as of 2026-05-25)

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

All systems operational

InsidersTradesSigma

US US6,790 companies

US-Listed Companies

Regulator: SEC (Form 4).

Technologie · 235m

Immix Biopharma, Inc.

Santé & Pharma · 541m

Santé & Pharma · 56m

Immune Therapeutics, Inc.

Santé & Pharma

Immuneering Corp

Santé & Pharma · 334m

Santé & Pharma · 165m

ImmunityBio, Inc.

Santé & Pharma · 8.3bn

ImmunoGen, Inc.

Santé & Pharma

Santé & Pharma · 2.4bn

Immunovant, Inc.

Santé & Pharma · 5.6bn

Impac Mortgage Holdings INC

Finance & Banque

← PreviousPage 65 of 136Next →

Impel Neuropharma INC

Santé & Pharma

Imperalis Holding CORP.

InMed Pharmaceuticals Inc.

Santé & Pharma · 6.5m

InPoint Commercial Real Estate Income, Inc.

Immobilier · 66m

Inari Medical, Inc.

Santé & Pharma

Inception Mining INC.

Indaptus Therapeutics, Inc.

Santé & Pharma · 5.1m

Independence Contract Drilling, Inc.

Independence Holding Co

Independence Realty Trust, INC.

Immobilier · 3.9bn

Independent Bank CORP

Finance & Banque · 3.7bn

Independent Bank Group, Inc.

Finance & Banque

India Globalization Capital, Inc.

Santé & Pharma · 23m

India Globalization Capital, Inc.

Santé & Pharma · 28m

India Globalization Capital, Inc.

Santé & Pharma · 28m

Indivior Pharmaceuticals, Inc.

Santé & Pharma · 4.3bn

Indivior Pharmaceuticals, Inc.

Santé & Pharma · 4.3bn

Indus Realty Trust, INC.

Industrial Logistics Properties Trust

Transport & Logistique · 524m

Infinite Group INC

Technologie · 23k

Infinity Natural Resources, INC.

Énergie · 289m

Infinity Pharmaceuticals, INC.

Santé & Pharma

Inflection Point Acquisition Corp.

Informatica Inc.

Information Analysis INC

Services aux entreprises

Information Services Group Inc.

Technologie · 197m

Technologie · 49bn

Infrastructure & Energy Alternatives, Inc.

Construction & BTP

Infrastructure & Energy Alternatives, Inc.

Construction & BTP

InfuSystem Holdings, Inc

Santé & Pharma · 181m

InfuSystem Holdings, Inc

Santé & Pharma · 181m

Ingersoll Rand Inc.

Industrie · 28bn

Chimie & Matériaux · 2.3bn

Ingles Markets INC

Agroalimentaire · 1.6bn

Ingram Micro Holding Corp

Distribution & Commerce · 5bn

Agroalimentaire · 6.9bn

Inhibikase Therapeutics, Inc.

Santé & Pharma · 270m

Inhibikase Therapeutics, Inc.

Santé & Pharma · 228m